FDA.reportPublic FDA data

tirzepatide 25 MG/ML Injectable Solution [Zepbound]

RxCUI
2732450
RxNorm name
tirzepatide 25 MG/ML Injectable Solution [Zepbound]
Display name
tirzepatide 25 MG/ML Injectable Solution [Zepbound]
Full name
tirzepatide 25 MG/ML Injectable Solution [Zepbound]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZepboundTIRZEPATIDEEli Lilly and Company487cd7e7-434c-4925-99fa-aa80b1cc776b2026-04-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2732450

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
487cd7e7-434c-4925-99fa-aa80b1cc776bzepbound 25 MG/ML Injectable Solution [PSN] · tirzepatide 25 MG/ML Injectable Solution [Zepbound] [SBD] · Zepbound 25 MG/ML Injectable Solution [SY]338These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422